D. R. Ghasemi

Dr. D. R. Ghasemi is a researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, specializing in pediatric neuro-oncology with a focus on molecular characterization of brain tumors, particularly medulloblastoma and ependymoma. Their work involves developing risk stratification models, identifying molecular drivers, and exploring novel therapeutic approaches for pediatric brain tumors.

Dr. Ghasemi's research focuses on the molecular mechanisms underlying pediatric brain tumors:

• Molecular subtyping of medulloblastoma and ependymoma based on genomic and transcriptomic features
• Development of risk stratification models incorporating molecular biomarkers
• Spatial transcriptomics applications to understand tumor heterogeneity and microenvironment
• Identification of oncogenic drivers and therapeutic targets in fusion-positive ependymomas
• Comparative genomics across species to validate tumor biology findings
• Integration of multi-omic data for improved diagnostic and prognostic classification

Dr. Ghasemi's publication record demonstrates expertise in translating molecular findings into clinically relevant insights for pediatric neuro-oncology. Their work frequently appears in high-impact journals including Nature Communications, Acta Neuropathologica, and Neuro-Oncology, reflecting significant contributions to understanding tumor biology and developing more precise diagnostic approaches.

Dr. Ghasemi actively collaborates with researchers across institutions, contributing to multi-center studies and clinical trials focused on improving outcomes for children with brain tumors. Their work bridges basic molecular research with clinical applications, aiming to develop more targeted and effective therapies for pediatric brain tumor patients.